Clinical Trial Detail

NCT ID NCT02466802
Title Study of Regorafenib and Sildenafil for Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Virginia Commonwealth University
Indications

Advanced Solid Tumor

Therapies

Regorafenib

Sildenafil

Age Groups: senior adult

No variant requirements are available.